Cibus (CBUS) Capital Expenditures (QoQ) (2016 - 2025)
Cibus (CBUS) Capital Expenditures (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.37% |
| Sep 30, 2025 | 16.13% |
| Jun 30, 2025 | -68.04% |
| Mar 31, 2025 | 419.64% |
| Dec 31, 2024 | -84.23% |
| Sep 30, 2024 | 110.06% |
| Jun 30, 2024 | -25.88% |
| Mar 31, 2024 | -49.22% |
| Dec 31, 2023 | -86.44% |
| Sep 30, 2023 | 491.43% |
| Dec 31, 2022 | -95.00% |
| Sep 30, 2022 | -70.43% |
| Jun 30, 2022 | 36.51% |
| Mar 31, 2022 | 150.00% |
| Dec 31, 2021 | 689.19% |
| Sep 30, 2021 | 97.07% |
| Jun 30, 2021 | -568.77% |
| Mar 31, 2021 | 117.98% |
| Dec 31, 2020 | -305.49% |
| Sep 30, 2020 | 250.00% |